viewXpediator PLC

Xpediator seeing high demand in most sectors despite coronavirus curbs

Trading in the quarter to end-March was broadly in line with management expectations

Xpediator PLC -
Still lots going on in transport

Xpediator PLC (LON:XPD) said activity in its transport services and solutions business has continued through the coronavirus (COVID-19) crisis with high demand in most sectors, though there has been a slowdown in some areas.

In a statement, the freight forwarding group said trading in the quarter to end-March was broadly in line with management expectations, with like-for-like revenues slightly up on the previous year though it has taken actions to protect the business during the pandemic.

Temporary pay reductions have been introduced across the group, capital investment reduced, and the final dividend for 2019 will be paid in shares rather than cash.

Stephen Blyth, chief executive commented: "2019 saw our revenues increase substantially by 19% to £213.2 million, and helping to end the year with strong cash balances."

“However, the outbreak of COVID-19 has changed the commercial world, with the duration and ultimate impact of the virus are as yet unknown. The group continues to seek acquisitions and the current crisis will, we believe, provide many opportunities to reach our target to grow the business over the next few years,” he added.

For the year 2019, like-for-like sales increased by 10.4% with profits of £2.18mln, against £5.6mln in 2018, the group reported.

House broker Cantor Fitzgerald said while there is significant uncertainty in European supply chains and consumer markets at the moment, Xpediator should prove resilient with its strong balance sheet, asset-light business model and flexible cost base.

Trading is seasonally stronger in the second half of the year the broker expects the company to remain healthily profitable in 2020, though it will review its forecasts when Europe starts to exit lockdown.

Cantor has a target price of 40p against a price of 28p, up 1% today.


-- adds broker comment, share price --

Quick facts: Xpediator PLC

Price: 37 GBX

Market: AIM
Market Cap: £52.4 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Xpediator PLC named herein, including the promotion by the Company of Xpediator PLC in any Content on the Site, the Company receives from said...


Market Report: FTSE jumps on AstraZeneca COVID-19 vaccine trial and easing...

FTSE 100 rallied in early trading on AstraZeneca’s COVID-19 vaccine trial and the easing of lockdown restrictions from December. London’s blue-chip index rose 20 to 6,371. AstraZeneca PLC (LON:AZN) announced that the coronavirus (COVID-19) vaccine it has developed with Oxford University was...

on 23/11/20

2 min read